Literature DB >> 24898255

Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.

Dane D Jensen1, Michelle L Halls1, Jane E Murphy2, Meritxell Canals1, Fiore Cattaruzza2, Daniel P Poole3, TinaMarie Lieu1, Hon-Wai Koon4, Charalabos Pothoulakis4, Nigel W Bunnett5.   

Abstract

Although the intracellular trafficking of G protein-coupled receptors controls specific signaling events, it is unclear how the spatiotemporal control of signaling contributes to complex pathophysiological processes such as inflammation. By using bioluminescence resonance energy transfer and superresolution microscopy, we found that substance P (SP) induces the association of the neurokinin 1 receptor (NK1R) with two classes of proteins that regulate SP signaling from plasma and endosomal membranes: the scaffolding proteins β-arrestin (βARRs) 1 and 2 and the transmembrane metallopeptidases ECE-1c and ECE-1d. In HEK293 cells and non-transformed human colonocytes, we observed that G protein-coupled receptor kinase 2 and βARR1/2 terminate plasma membrane Ca(2+) signaling and initiate receptor trafficking to endosomes that is necessary for sustained activation of ERKs in the nucleus. βARRs deliver the SP-NK1R endosomes, where ECE-1 associates with the complex, degrades SP, and allows the NK1R, freed from βARRs, to recycle. Thus, both ECE-1 and βARRs mediate the resensitization of NK1R Ca(2+) signaling at the plasma membrane. Sustained exposure of colonocytes to SP activates NF-κB and stimulates IL-8 secretion. This proinflammatory signaling is unaffected by inhibition of the endosomal ERK pathway but is suppressed by ECE-1 inhibition or βARR2 knockdown. Inhibition of protein phosphatase 2A, which also contributes to sustained NK1R signaling at the plasma membrane, similarly attenuates IL-8 secretion. Thus, the primary function of βARRs and ECE-1 in SP-dependent inflammatory signaling is to promote resensitization, which allows the sustained NK1R signaling from the plasma membrane that drives inflammation.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Arrestins; Cell Signaling; G Protein-coupled Receptor (GPCR); Inflammation; Intracellular Trafficking; Neuropeptide; Receptor Endocytosis

Mesh:

Substances:

Year:  2014        PMID: 24898255      PMCID: PMC4106342          DOI: 10.1074/jbc.M114.578179

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Endosomes: a legitimate platform for the signaling train.

Authors:  Jane E Murphy; Benjamin E Padilla; Burcu Hasdemir; Graeme S Cottrell; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

2.  Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.

Authors:  Jiyuan Sun; Xin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

3.  Characterization of G-protein coupled receptor kinase interaction with the neurokinin-1 receptor using bioluminescence resonance energy transfer.

Authors:  Rasmus Jorgensen; Nicholas D Holliday; Jakob L Hansen; Milka Vrecl; Anders Heding; Thue W Schwartz; Christian E Elling
Journal:  Mol Pharmacol       Date:  2007-11-06       Impact factor: 4.436

4.  Endosomal endothelin-converting enzyme-1: a regulator of beta-arrestin-dependent ERK signaling.

Authors:  Graeme S Cottrell; Benjamin E Padilla; Silvia Amadesi; Daniel P Poole; Jane E Murphy; Markus Hardt; Dirk Roosterman; Martin Steinhoff; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

5.  Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.

Authors:  Dirk Roosterman; Graeme S Cottrell; Benjamin E Padilla; Laurent Muller; Christopher B Eckman; Nigel W Bunnett; Martin Steinhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

6.  Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation.

Authors:  F Cattaruzza; G S Cottrell; N Vaksman; N W Bunnett
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

7.  Effects of the endothelin-converting enzyme inhibitor SM-19712 in a mouse model of dextran sodium sulfate-induced colitis.

Authors:  Seungjun Lee; Patsy R Carter; Megan N Watts; Jianxiong R Bao; Norman R Harris
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

8.  A genetically encoded fluorescent sensor of ERK activity.

Authors:  Christopher D Harvey; Anka G Ehrhardt; Cristina Cellurale; Haining Zhong; Ryohei Yasuda; Roger J Davis; Karel Svoboda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

9.  Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation.

Authors:  Hongying Wang; France Moreau; Christina L Hirota; Wallace K MacNaughton
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

10.  Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression.

Authors:  Hongkuan Fan; Louis M Luttrell; George E Tempel; Joseph J Senn; Perry V Halushka; James A Cook
Journal:  Mol Immunol       Date:  2007-04-06       Impact factor: 4.407

View more
  9 in total

1.  Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.

Authors:  Rebecca E Yarwood; Wendy L Imlach; TinaMarie Lieu; Nicholas A Veldhuis; Dane D Jensen; Carmen Klein Herenbrink; Luigi Aurelio; Zhijian Cai; MacDonald J Christie; Daniel P Poole; Christopher J H Porter; Peter McLean; Gareth A Hicks; Pierangelo Geppetti; Michelle L Halls; Meritxell Canals; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

2.  Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system.

Authors:  Daniel P Poole; TinaMarie Lieu; Juan Carlos Pelayo; Emily M Eriksson; Nicholas A Veldhuis; Nigel W Bunnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

3.  Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.

Authors:  Nestor Nivardo Jiménez-Vargas; Yang Yu; Dane D Jensen; Diana Daeun Bok; Matthew Wisdom; Rocco Latorre; Cintya Lopez; Josue O Jaramillo-Polanco; Claudius Degro; Mabel Guzman-Rodriguez; Quentin Tsang; Zachary Snow; Brian L Schmidt; David E Reed; Alan Edward Lomax; Kara Gross Margolis; Christoph Stein; Nigel W Bunnett; Stephen J Vanner
Journal:  Gut       Date:  2021-03-30       Impact factor: 23.059

4.  Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.

Authors:  Dane D Jensen; TinaMarie Lieu; Michelle L Halls; Nicholas A Veldhuis; Wendy L Imlach; Quynh N Mai; Daniel P Poole; Tim Quach; Luigi Aurelio; Joshua Conner; Carmen Klein Herenbrink; Nicholas Barlow; Jamie S Simpson; Martin J Scanlon; Bimbil Graham; Adam McCluskey; Phillip J Robinson; Virginie Escriou; Romina Nassini; Serena Materazzi; Pierangelo Geppetti; Gareth A Hicks; Macdonald J Christie; Christopher J H Porter; Meritxell Canals; Nigel W Bunnett
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

5.  Protein Kinase D and Gβγ Subunits Mediate Agonist-evoked Translocation of Protease-activated Receptor-2 from the Golgi Apparatus to the Plasma Membrane.

Authors:  Dane D Jensen; Peishen Zhao; Nestor N Jimenez-Vargas; TinaMarie Lieu; Marina Gerges; Holly R Yeatman; Meritxell Canals; Stephen J Vanner; Daniel P Poole; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2016-03-30       Impact factor: 5.157

6.  Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain.

Authors:  Nestor N Jimenez-Vargas; Jing Gong; Matthew J Wisdom; Dane D Jensen; Rocco Latorre; Alan Hegron; Shavonne Teng; Jesse J DiCello; Pradeep Rajasekhar; Nicholas A Veldhuis; Simona E Carbone; Yang Yu; Cintya Lopez-Lopez; Josue Jaramillo-Polanco; Meritxell Canals; David E Reed; Alan E Lomax; Brian L Schmidt; Kam W Leong; Stephen J Vanner; Michelle L Halls; Nigel W Bunnett; Daniel P Poole
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-16       Impact factor: 11.205

7.  Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy.

Authors:  Eunice E To; Ross Vlahos; Raymond Luong; Michelle L Halls; Patrick C Reading; Paul T King; Christopher Chan; Grant R Drummond; Christopher G Sobey; Brad R S Broughton; Malcolm R Starkey; Renee van der Sluis; Sharon R Lewin; Steven Bozinovski; Luke A J O'Neill; Tim Quach; Christopher J H Porter; Doug A Brooks; John J O'Leary; Stavros Selemidis
Journal:  Nat Commun       Date:  2017-07-12       Impact factor: 14.919

8.  Internalized GPCRs as Potential Therapeutic Targets for the Management of Pain.

Authors:  Jeffri S Retamal; Paulina D Ramírez-García; Priyank A Shenoy; Daniel P Poole; Nicholas A Veldhuis
Journal:  Front Mol Neurosci       Date:  2019-11-12       Impact factor: 5.639

9.  Mice expressing fluorescent PAR2 reveal that endocytosis mediates colonic inflammation and pain.

Authors:  Rocco Latorre; Alan Hegron; Chloe J Peach; Shavonne Teng; Raquel Tonello; Jeffri S Retamal; Rafael Klein-Cloud; Diana Bok; Dane D Jensen; Lena Gottesman-Katz; Jeanette Rientjes; Nicholas A Veldhuis; Daniel P Poole; Brian L Schmidt; Charalabos H Pothoulakis; Carl Rankin; Ying Xie; Hon Wai Koon; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-08       Impact factor: 12.779

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.